Literature DB >> 23893753

Persistent human herpesvirus-6 infection in patients with an inherited form of the virus.

Shara N Pantry1, Maria M Medveczky, Jesse H Arbuckle, Janos Luka, Jose G Montoya, Jianhong Hu, Rolf Renne, Daniel Peterson, Joshua C Pritchett, Dharam V Ablashi, Peter G Medveczky.   

Abstract

Human herpesvirus-6 (HHV-6)A and 6B are ubiquitous betaherpesviruses viruses with lymphotropic and neurotropic potential. As reported earlier, these viruses establish latency by integration into the telomeres of host chromosomes. Chromosomally integrated HHV-6 (CIHHV-6) can be transmitted vertically from parent to child. Some CIHHV-6 patients are suffering from neurological symptoms, while others remain asymptomatic. Four patients with CIHHV-6 and CNS dysfunction were treated with valganciclovir or foscarnet. HHV-6 replication was detected by reverse transcriptase polymerase chain reaction amplification of a late envelope glycoprotein. In this study we also compared the inherited and persistent HHV-6 viruses by DNA sequencing. The prevalence of CIHHV-6 in this cohort of adult patients from the USA suffering from a wide range of neurological symptoms including long-term fatigue were found significantly greater than the reported 0.8% in the general population. Long-term antiviral therapy inhibited HHV-6 replication as documented by loss of viral mRNA production. Sequence comparison of the mRNA and the inherited viral genome revealed that the transcript is produced by an exogenous virus. In conclusion, the data presented here document that some individuals with CIHHV-6 are infected persistently with exogenous HHV-6 strains that lead to a wide range of neurological symptoms; the proposed name for this condition is inherited herpesvirus 6 syndrome or IHS.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  HHV-6; antiviral drug treatment; chronic fatigue syndrome; human herpesvirus 6; integration

Mesh:

Substances:

Year:  2013        PMID: 23893753      PMCID: PMC3779660          DOI: 10.1002/jmv.23685

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  30 in total

1.  Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.

Authors:  D V Ablashi; H B Eastman; C B Owen; M M Roman; J Friedman; J B Zabriskie; D L Peterson; G R Pearson; J E Whitman
Journal:  J Clin Virol       Date:  2000-05       Impact factor: 3.168

2.  Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus.

Authors:  P D Griffiths; M Ait-Khaled; C P Bearcroft; D A Clark; A Quaglia; S E Davies; A K Burroughs; K Rolles; I M Kidd; S N Knight; S M Noibi; A V Cope; A N Phillips; V C Emery
Journal:  J Med Virol       Date:  1999-12       Impact factor: 2.327

3.  Development of reverse transcriptase PCR assays for detection of active human herpesvirus 6 infection.

Authors:  G Van den Bosch; G Locatelli; L Geerts; G Fagà; M Ieven; H Goossens; D Bottiger; B Oberg; P Lusso; Z N Berneman
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

4.  Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A.

Authors:  C B Hall; M T Caserta; K C Schnabel; C Long; L G Epstein; R A Insel; S Dewhurst
Journal:  Clin Infect Dis       Date:  1998-01       Impact factor: 9.079

5.  Detection of human herpesvirus 6 by reverse transcription-PCR.

Authors:  R A Norton; M T Caserta; C B Hall; K Schnabel; P Hocknell; S Dewhurst
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

6.  Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection.

Authors:  I M Kidd; D A Clark; C A Sabin; D Andrew; A F Hassan-Walker; P Sweny; P D Griffiths; V C Emery
Journal:  Transplantation       Date:  2000-06-15       Impact factor: 4.939

7.  Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7).

Authors:  Caroline Breese Hall; Mary T Caserta; Kenneth C Schnabel; Christian Boettrich; Michael P McDermott; Geraldine K Lofthus; Jennifer A Carnahan; Stephen Dewhurst
Journal:  J Pediatr       Date:  2004-10       Impact factor: 4.406

8.  Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA.

Authors:  Keiko Tanaka-Taya; Junji Sashihara; Hiroki Kurahashi; Kiyoko Amo; Hiromi Miyagawa; Kazuhiro Kondo; Shintaro Okada; Koichi Yamanishi
Journal:  J Med Virol       Date:  2004-07       Impact factor: 2.327

9.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

10.  Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo.

Authors:  G Torelli; P Barozzi; R Marasca; P Cocconcelli; E Merelli; L Ceccherini-Nelli; S Ferrari; M Luppi
Journal:  J Med Virol       Date:  1995-07       Impact factor: 2.327

View more
  12 in total

1.  Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).

Authors:  Mark N Polizzotto; Thomas S Uldrick; Kathleen M Wyvill; Karen Aleman; Vickie Marshall; Victoria Wang; Denise Whitby; Stefania Pittaluga; Elaine S Jaffe; Corina Millo; Giovanna Tosato; Richard F Little; Seth M Steinberg; Irini Sereti; Robert Yarchoan
Journal:  Clin Infect Dis       Date:  2015-12-12       Impact factor: 9.079

2.  Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR.

Authors:  Ruth Hall Sedlak; Linda Cook; Meei-Li Huang; Amalia Magaret; Danielle M Zerr; Michael Boeckh; Keith R Jerome
Journal:  Clin Chem       Date:  2014-03-04       Impact factor: 8.327

Review 3.  Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials.

Authors:  Joshua A Hill; Danielle M Zerr
Journal:  Curr Opin Virol       Date:  2014-10-04       Impact factor: 7.090

4.  Optimisation of a quantitative polymerase chain reaction-based strategy for the detection and quantification of human herpesvirus 6 DNA in patients undergoing allogeneic haematopoietic stem cell transplantation.

Authors:  Miriam Y H Ueda; Paulo G Alvarenga; Juliana M Real; Eloisa de Sá Moreira; Aripuanã Watanabe; Ana Maria Passos-Castilho; Matheus Vescovi; Yana Novis; Vanderson Rocha; Adriana Seber; Jose S R Oliveira; Celso A Rodrigues; Celso F H Granato
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-06-02       Impact factor: 2.743

5.  Complete Genome Sequence of Germline Chromosomally Integrated Human Herpesvirus 6A and Analyses Integration Sites Define a New Human Endogenous Virus with Potential to Reactivate as an Emerging Infection.

Authors:  Joshua Tweedy; Maria Alexandra Spyrou; Max Pearson; Dirk Lassner; Uwe Kuhl; Ursula A Gompels
Journal:  Viruses       Date:  2016-01-15       Impact factor: 5.048

Review 6.  Latency, Integration, and Reactivation of Human Herpesvirus-6.

Authors:  Shara N Pantry; Peter G Medveczky
Journal:  Viruses       Date:  2017-07-24       Impact factor: 5.048

Review 7.  Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.

Authors:  Joseph Ongrádi; Dharam V Ablashi; Tetsushi Yoshikawa; Balázs Stercz; Masao Ogata
Journal:  J Neurovirol       Date:  2016-08-18       Impact factor: 2.643

8.  Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

Authors:  Jonas Blomberg; Muhammad Rizwan; Agnes Böhlin-Wiener; Amal Elfaitouri; Per Julin; Olof Zachrisson; Anders Rosén; Carl-Gerhard Gottfries
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

Review 9.  Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology.

Authors:  Jessica M Hogestyn; David J Mock; Margot Mayer-Proschel
Journal:  Neural Regen Res       Date:  2018-02       Impact factor: 5.135

Review 10.  A Molecular Neurobiological Approach to Understanding the Aetiology of Chronic Fatigue Syndrome (Myalgic Encephalomyelitis or Systemic Exertion Intolerance Disease) with Treatment Implications.

Authors:  Jean A Monro; Basant K Puri
Journal:  Mol Neurobiol       Date:  2018-02-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.